The Institute of Oncology and Molecular Medicine of Asturias, known by its initials IMOMA, is a newly founded company dedicated to preventing, diagnosing and treating cancer. Its objective is to undertake care and research activities, mainly in the field of oncology, in order to provide patients with excellent care and contribute to the knowledge of the mechanisms that determine states of health and illness. In order to provide comprehensive oncological care, IMOMA has a Translational Clinical Oncology Unit and a Molecular Medicine Laboratory.

The María Cristina Masaveu Peterson Foundation, which has among its founding objects the promotion of scientific research, has supported IMOMA since 2008 in the development of a research project on genomic sequencing of a new generation applied to the study of cancer, with the aim of to identify new genes of said disease, under the direction of doctors Rubén Cabanillas Farpón, Juan Cadiñanos Bañales, and through a research grant granted by  the Foundation to Jorge de la Rosa Saa